Brief: Jounce Therapeutics & Redx Pharma Agree to Merge

Redx Pharma

23/02/2023 07:49

Feb 23 (Reuters) - Redx Pharma PLC  REDX.L :
    * JOUNCE THERAPEUTICS REDX PHARMA PLC  - RECOMMENDED
BUSINESS
COMBINATION
    * REDX PHARMA - BOARDS OF REDX AND JOUNCE REACHED AGREEMENT
ON
TERMS AND CONDITIONS OF A UNANIMOUSLY RECOMMENDED ALL SHARE
MERGER
    * REDX PHARMA PLC - SHAREHOLDERS SHALL BE ENTITLED TO
RECEIVE
0.2105 JOUNCE SHARES IN EXCHANGE FOR EACH REDX SHARE
    * REDX PHARMA PLC - JOUNCE INTENDS TO CONDUCT A REVERSE
STOCK
SPLIT OF ITS SHARES IN CONJUNCTION WITH DEAL
    * REDX PHARMA - IF REVERSE STOCK SPLIT APPROVED BY JOUNCE
SHAREHOLDERS, EXCHANGE RATIO WILL BE ADJUSTED TO 0.0421 JOUNCE
SHARES
    * REDX PHARMA PLC - AFTER DEAL, BOARD OF ENLARGED GROUP IS
EXPECTED TO HAVE NINE MEMBERS

Source text for Eikon:  ID:nRSW8260Qa 
Further company coverage:  REDX.L 
 ((Reuters.Briefs@thomsonreuters.com;))